Novo Nordisk A/S (ADR) (NYSE:NVO)
CAPS Rating:
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
Recs
Alzhiemer's trials with a diabetes drug?
That's cool, good company, GO Jags
Thanx man! For more Foolish Football talk, go to;
http://boards.fool.com/77s-foolish-house-of-pigskin-113264.aspx?mid=29449709